Sameek Roychowdhury

Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration.

Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.

Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.

Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.

Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.

Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies.

IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.

Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

Cytokine therapy for cancer: antigen presentation.

Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.

Managing resistance in chronic myeloid leukemia.

Personalized oncology through integrative high-throughput sequencing: a pilot study.

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.

Identification of targetable FGFR gene fusions in diverse cancers.

Advancing precision medicine for prostate cancer through genomics.

Implementing personalized cancer genomics in clinical trials.

Activating ESR1 mutations in hormone-resistant metastatic breast cancer.

Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

Translating genomics for precision cancer medicine.

Comparison of custom capture for targeted next-generation DNA sequencing.

Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.

Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing.

Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations.

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.

Translating cancer genomes and transcriptomes for precision oncology.

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.

The Bayesian basket design for genomic variant-driven phase II trials.